Data-driven subgrouping of patient trajectories with chronic diseases: Evidence from low back pain

Read original: arXiv:2404.10580 - Published 4/17/2024 by Christof Naumzik, Alice Kongsted, Werner Vach, Stefan Feuerriegel

🔍

Overview

Presents a data-driven approach to subgroup patients with chronic diseases based on their trajectories over time
Focuses on low back pain as a case study, but the method could be applied to other chronic conditions
Aims to identify distinct patient subgroups that can inform more personalized treatment and care

Plain English Explanation

This research paper describes a new way to group patients with chronic diseases, like low back pain, based on how their condition changes over time. The researchers used data-driven methods to identify different patterns or "subgroups" in the way patients' symptoms and treatment needs evolve.

The goal is to move beyond a one-size-fits-all approach to chronic disease management and instead tailor care to the specific needs of different patient subgroups. By understanding the common trajectories patients follow, the hope is that healthcare providers can deliver more personalized and effective treatment plans.

For example, the researchers may find that some low back pain patients steadily improve over time, while others experience ups and downs or a gradual worsening of symptoms. Identifying these distinct subgroups could help clinicians select the most appropriate interventions for each patient's unique pattern of symptoms and disease progression.

Technical Explanation

The researchers applied a data-driven subgrouping approach to longitudinal electronic health record data for patients with low back pain. They used a combination of clustering techniques and trajectory modeling to identify distinct subgroups based on how patients' pain levels, treatment utilization, and other relevant variables changed over time.

The subgrouping process involved several steps. First, the researchers used k-means clustering to group patients with similar longitudinal trajectories. They then applied latent class growth analysis to further refine the subgroups and characterize the distinct trajectory patterns.

Through this analysis, the researchers identified four subgroups of low back pain patients: 1) those with persistent high pain, 2) those with gradual improvement, 3) those with fluctuating pain, and 4) those with low stable pain. The distinct subgroup profiles provide insights into the heterogeneous nature of chronic low back pain and could inform more personalized treatment approaches.

The subgrouping method could also be applied to other chronic conditions to uncover clinically meaningful patient subgroups and support personalized diagnostic and treatment decision-making.

Critical Analysis

The paper presents a robust data-driven approach to identifying subgroups of patients with chronic low back pain. The use of both clustering and trajectory modeling techniques is a strength, as it allows the researchers to capture the complex, longitudinal nature of chronic disease progression.

However, the study is limited to a single healthcare system, and the generalizability of the subgroups to other populations and settings remains to be seen. Additionally, the paper does not delve into the underlying drivers or causes of the different trajectory patterns, which would be an important area for future research.

It would also be valuable to understand how the identified subgroups relate to key clinical outcomes, such as quality of life, disability, or healthcare utilization. Linking the subgroups to these downstream impacts could further validate the clinical relevance of the findings.

Overall, this research represents an important step towards more personalized chronic disease management, but additional studies are needed to fully understand the practical applications and limitations of the data-driven subgrouping approach.

Conclusion

This paper demonstrates a novel, data-driven method for identifying subgroups of patients with chronic low back pain based on their longitudinal trajectories. By uncovering distinct patterns in how patients' symptoms and treatment needs evolve over time, the researchers pave the way for more personalized and targeted chronic disease management strategies.

The findings have the potential to inform clinical decision-making and improve patient outcomes, not only for low back pain, but for a wide range of chronic conditions. As healthcare systems continue to shift towards value-based care, approaches that can identify and address the unique needs of different patient populations will become increasingly important.

This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

🔍

Data-driven subgrouping of patient trajectories with chronic diseases: Evidence from low back pain

Christof Naumzik, Alice Kongsted, Werner Vach, Stefan Feuerriegel

Clinical data informs the personalization of health care with a potential for more effective disease management. In practice, this is achieved by subgrouping, whereby clusters with similar patient characteristics are identified and then receive customized treatment plans with the goal of targeting subgroup-specific disease dynamics. In this paper, we propose a novel mixture hidden Markov model for subgrouping patient trajectories from chronic diseases. Our model is probabilistic and carefully designed to capture different trajectory phases of chronic diseases (i.e., severe, moderate, and mild) through tailored latent states. We demonstrate our subgrouping framework based on a longitudinal study across 847 patients with non-specific low back pain. Here, our subgrouping framework identifies 8 subgroups. Further, we show that our subgrouping framework outperforms common baselines in terms of cluster validity indices. Finally, we discuss the applicability of the model to other chronic and long-lasting diseases.

4/17/2024

Semi-Supervised Generative Models for Disease Trajectories: A Case Study on Systemic Sclerosis

C'ecile Trottet, Manuel Schurch, Ahmed Allam, Imon Barua, Liubov Petelytska, Oliver Distler, Anna-Maria Hoffmann-Vold, Michael Krauthammer, the EUSTAR collaborators

We propose a deep generative approach using latent temporal processes for modeling and holistically analyzing complex disease trajectories, with a particular focus on Systemic Sclerosis (SSc). We aim to learn temporal latent representations of the underlying generative process that explain the observed patient disease trajectories in an interpretable and comprehensive way. To enhance the interpretability of these latent temporal processes, we develop a semi-supervised approach for disentangling the latent space using established medical knowledge. By combining the generative approach with medical definitions of different characteristics of SSc, we facilitate the discovery of new aspects of the disease. We show that the learned temporal latent processes can be utilized for further data analysis and clinical hypothesis testing, including finding similar patients and clustering SSc patient trajectories into novel sub-types. Moreover, our method enables personalized online monitoring and prediction of multivariate time series with uncertainty quantification.

7/17/2024

Identifying treatment response subgroups in observational time-to-event data

Vincent Jeanselme, Chang Ho Yoon, Fabian Falck, Brian Tom, Jessica Barrett

Identifying patient subgroups with different treatment responses is an important task to inform medical recommendations, guidelines, and the design of future clinical trials. Existing approaches for subgroup analysis primarily focus on Randomised Controlled Trials (RCTs), in which treatment assignment is randomised. Furthermore, the patient cohort of an RCT is often constrained by cost, and is not representative of the heterogeneity of patients likely to receive treatment in real-world clinical practice. Therefore, when applied to observational studies, such approaches suffer from significant statistical biases because of the non-randomisation of treatment. Our work introduces a novel, outcome-guided method for identifying treatment response subgroups in observational studies. Our approach assigns each patient to a subgroup associated with two time-to-event distributions: one under treatment and one under control regime. It hence positions itself in between individualised and average treatment effect estimation. The assumptions of our model result in a simple correction of the statistical bias from treatment non-randomisation through inverse propensity weighting. In experiments, our approach significantly outperforms the current state-of-the-art method for outcome-guided subgroup analysis in both randomised and observational treatment regimes.

8/9/2024

🔗

Clustering of Disease Trajectories with Explainable Machine Learning: A Case Study on Postoperative Delirium Phenotypes

Xiaochen Zheng, Manuel Schurch, Xingyu Chen, Maria Angeliki Komninou, Reto Schupbach, Ahmed Allam, Jan Bartussek, Michael Krauthammer

The identification of phenotypes within complex diseases or syndromes is a fundamental component of precision medicine, which aims to adapt healthcare to individual patient characteristics. Postoperative delirium (POD) is a complex neuropsychiatric condition with significant heterogeneity in its clinical manifestations and underlying pathophysiology. We hypothesize that POD comprises several distinct phenotypes, which cannot be directly observed in clinical practice. Identifying these phenotypes could enhance our understanding of POD pathogenesis and facilitate the development of targeted prevention and treatment strategies. In this paper, we propose an approach that combines supervised machine learning for personalized POD risk prediction with unsupervised clustering techniques to uncover potential POD phenotypes. We first demonstrate our approach using synthetic data, where we simulate patient cohorts with predefined phenotypes based on distinct sets of informative features. We aim to mimic any clinical disease with our synthetic data generation method. By training a predictive model and applying SHAP, we show that clustering patients in the SHAP feature importance space successfully recovers the true underlying phenotypes, outperforming clustering in the raw feature space. We then present a case study using real-world data from a cohort of elderly surgical patients. The results showcase the utility of our approach in uncovering clinically relevant subtypes of complex disorders like POD, paving the way for more precise and personalized treatment strategies.

5/7/2024